A newsletter co-hosted by the Wyss Institute at Harvard University, focusing on the intersection of AI, biology, and healthcare to transform medicine, with emphasis on AI-driven drug discovery and accelerating life-saving therapies.

Daily insights into health care innovations, including AI's role in drug discovery, repurposing existing drugs for rare diseases, and accelerating treatments for conditions like idiopathic pulmonary fibrosis and ALS.

Top stories in biotechnology, drug discovery, and pharma, highlighting AI-enabled milestones like clinical trials for AI-discovered drugs targeting idiopathic pulmonary fibrosis and regulatory challenges in AI therapeutics.

Breaking news and breakthroughs on AI applications in healthcare, covering precision medicine, AI-discovered drugs for cancer and neurological disorders, and accelerated timelines in psychiatric drug design.